
Sign up to save your podcasts
Or


Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween?
We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We bring on BridgeBio CEO Neil Kumar to discuss the company’s positive Phase 3 readouts and our colleague Jason Mast to discuss Moderna’s struggles following its Covid-19 vaccine boom.
By STAT4.5
320320 ratings
Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween?
We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We bring on BridgeBio CEO Neil Kumar to discuss the company’s positive Phase 3 readouts and our colleague Jason Mast to discuss Moderna’s struggles following its Covid-19 vaccine boom.

1,976 Listeners

755 Listeners

1,096 Listeners

816 Listeners

498 Listeners

127 Listeners

6,118 Listeners

62 Listeners

87 Listeners

35 Listeners

5,594 Listeners

55 Listeners

21 Listeners

397 Listeners

15 Listeners

12 Listeners